Trading by management and close relations of management
February 02, 2024 08:13 ET
|
Novozymes A/S
Trading by management and close relations of management In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and...
Settlement of the combination of Novozymes and Chr. Hansen Holding successfully completed
February 02, 2024 02:28 ET
|
Novozymes A/S
Settlement of the combination of Novozymes and Chr. Hansen Holding successfully completed February 2, 2024Company announcement No. 07 On January 29, 2024, following the satisfaction of...
Legacy Novozymes delivers solid last full-year results
February 01, 2024 02:00 ET
|
Novozymes A/S
Legacy Novozymes is delivering solid growth and earnings in a year characterized by changing market demands, with 6% organic sales growth in Q4 and 5% organic sales growth in 2023. This marks...
Results update for 2023 – unaudited
February 01, 2024 01:59 ET
|
Novozymes A/S
6% organic sales growth in Q4 and 5% for the full year with solid margins and free cash flow generation As Novozymes just closed the combination with Chr. Hansen on January 29, and the annual...
Total number of voting rights and capital on January 31, 2024
January 31, 2024 08:20 ET
|
Novozymes A/S
Total number of voting rights and capital on January 31, 2024 January 31, 2024Company announcement No. 05 Referring to company announcement 02, on January 29, 2024, where Novozymes A/S...
Trading by management and close relations of management
January 29, 2024 09:59 ET
|
Novozymes A/S
January 29, 2024Company announcement No. 04 Trading by management and close relations of management In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on...
Major shareholder announcement
January 29, 2024 07:13 ET
|
Novozymes A/S
Major shareholder announcement January 29, 2024Company announcement No. 03 On January 29, 2024, following the satisfaction of all conditions precedent, the combination of...
The combination of Novozymes and Chr. Hansen is now successfully completed, creating Novonesis – a leading global biosolutions partner
January 29, 2024 05:27 ET
|
Novozymes A/S
Today, the proposed combination of the legacy companies Novozymes and Chr. Hansen is successfully completed, establishing the company Novonesis. Novonesis is a world-leading biosolutions partner for...
Completion of the combination between Novozymes and Chr. Hansen
January 29, 2024 05:25 ET
|
Novozymes A/S
Please read the full announcement in PDF
Attachment
2024_02_Completion_Of_The_Combination
...
All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen
January 26, 2024 06:06 ET
|
Novozymes A/S
Please read the full announcement in PDF
Attachment
2024_01_All_Regulatory_Approvals_Obtained
...